Cargando…
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance
Molecular testing for genomic variants is recommended in advanced non-small cell lung cancer (NSCLC). Standard tissue biopsy is sometimes infeasible, procedurally risky, or insufficient in tumor tissue quantity. We present the analytical validation and concordance study of EGFR variants using a new...
Autores principales: | Schwartzberg, Lee S., Horinouchi, Hidehito, Chan, David, Chernilo, Sara, Tsai, Michaela L., Isla, Dolores, Escriu, Carles, Bennett, John P., Clark-Langone, Kim, Svedman, Christer, Tomasini, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314769/ https://www.ncbi.nlm.nih.gov/pubmed/32596507 http://dx.doi.org/10.1038/s41698-020-0118-x |
Ejemplares similares
-
Concordance between cryobiopsy and forceps biopsy specimens in assessment of immunohistochemistry staining for non-small cell lung carcinoma
por: Nishimatsu, Kanako, et al.
Publicado: (2023) -
Role of multimodality therapy in cIIIA-N2 non–small cell lung cancer: perspective(§)
por: Horinouchi, Hidehito
Publicado: (2016) -
To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
por: Horinouchi, Hidehito
Publicado: (2020) -
Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer
por: Taniguchi, Fumitaka, et al.
Publicado: (2021) -
Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer
por: Liu, Minetta C., et al.
Publicado: (2022)